Results 311 to 320 of about 141,118 (333)

HIV pre-exposure prophylaxis (PrEP)

BMJ, 2019
### What you need to know A 22 year old man attends a sexual health clinic. Six months previously, he completed a course of HIV post-exposure prophylaxis for anal receptive intercourse without a condom. Since then, he reports six anal receptive sexual exposures without a condom. He has been treated at another sexual health clinic for rectal gonorrhoea.
Ethan, Tumarkin, Mark J, Siedner, Isaac I, Bogoch   +2 more
openaire   +2 more sources

HIV Pre-Exposure Prophylaxis

Infectious Disease Clinics of North America
Pre-exposure prophylaxis (PrEP) of human immunodeficiency virus (HIV) represents the most significant breakthrough in the HIV prevention field over the past decade. PrEP is an effective strategy in preventing the transmission of HIV across all populations, providing high adherence.
Geoffroy, Liegeon, Constance, Delaugerre, Jean-Michel, Molina   +2 more
openaire   +2 more sources

Pre-exposure prophylaxis: making history

Sexually Transmitted Infections, 2017
August 2016 was a truly momentous month for HIV prevention in the UK. We saw the National AIDS Trust successfully challenge NHS England with regards to the withdrawal of pre-exposure prophylaxis “PrEP” from the NHS specialised commissioning process.1 There was huge media representation of the case, with PrEP making the main headline on BBC News on ...
openaire   +2 more sources

Pre-Exposure Prophylaxis: An Ethical Discussion

Journal of the Association of Nurses in AIDS Care, 2013
Recent reports have indicated that HIV prevention in the United States is undergoing a paradigm shift. This has involved movement away from traditional behavior-change approaches to more medical and biological interventions such as microbicides, circumcision, and treatment as a prevention strategy (Buchbinder, 2007; Nodin, Carballo-Dieguez, Ventuneac ...
Stefan, Rowniak, Carmen, Portillo
openaire   +2 more sources

Tixagevimab–Cilgavimab: COVID-19 Pre-Exposure Prophylaxis

Clinical Journal of Oncology Nursing, 2022
Tixagevimab-cilgavimab is the only nonvaccine drug currently authorized in the United States for the prevention of COVID-19 infection in individuals who are moderately to severely immunocompromised or unable to receive COVI.
openaire   +2 more sources

Oral pre-exposure prophylaxis for HIV prevention

Trends in Pharmacological Sciences, 2010
In the absence of an effective vaccine, HIV continues to spread worldwide, emphasizing the need for new biomedical interventions to limit its transmission. Appreciation of the challenges that HIV has to face to initiate an infection mucosally has spurred interest in evaluating the use of antiretroviral drugs to prevent infection.
J Gerardo, García-Lerma, Lynn, Paxton, Peter H, Kilmarx, Walid, Heneine   +3 more
openaire   +2 more sources

[Focus on pre-exposure prophylaxis].

Revue de l'infirmiere, 2013
Pre-exposure prophylaxis currently has no market authorisation in France, but is still evaluated. This article presents an additional tool for risk reduction, currently the subject of studies.
Emma, Torres, Jean-Luc, Meynard
openaire   +1 more source

Online Prescriptions to HIV Pre-Exposure Prophylaxis and Pre-Exposure Prophylaxis Uptake

AIDS Patient Care and STDs, 2020
Lexie, Wille, Mike C, Parent
openaire   +2 more sources

Pre-exposure prophylaxis in the perinatal period

The Lancet HIV
Women in sub-Saharan Africa are at high risk for HIV acquisition during pregnancy and postpartum periods, which puts the health of perinatal people at risk, but also contributes to new paediatric infections. Pre-exposure prophylaxis (PrEP) to prevent HIV is a highly effective intervention to prevent HIV acquisition.
Sheree, Schwartz, Friday, Saidi
openaire   +2 more sources

Prescribing pre-exposure prophylaxis therapy

Journal of Prescribing Practice
Deborah Robertson provides an overview of recently published articles that may be of interest to non-medical prescribers. Should you wish to look at any of the papers in more detail, a full reference is provided
openaire   +1 more source